We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Multiple sclerosis drug

News List

FDA Warns of Rare Stroke Risk With Multiple Sclerosis Drug drugs
December 06, 2018
A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.....
FDA warns risks with multiple sclerosis drug Lemtrada (alemtuzumab) fda
November 30, 2018
FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)
Multiple sclerosis drug slows brain shrinkage in NIH-funded trial pharmaceutical-technology
September 03, 2018
A new brain imaging clinical trial funded by the National Institutes of Health (NIH) has showed that multiple sclerosis drug ibudilast was better than a placebo at slowing down brain shrinkage.